In Vivo Ryr 2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia-Reference-Cited by-同舟云学术

In Vivo Ryr 2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia

Published:2018-09-28 Issue:8 Volume:123 Page:953-963
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Pan Xiaolu¹²,Philippen Leonne¹²,Lahiri Satadru K.¹²,Lee Ciaran³,Park So Hyun³,Word Tarah A.¹²,Li Na¹²⁴,Jarrett Kelsey E.²,Gupta Rajat²,Reynolds Julia O.¹²,Lin Jean¹,Bao Gang³,Lagor William R.²,Wehrens Xander H.T.¹²⁴⁵⁶

Affiliation:

1. From the Cardiovascular Research Institute (X.P., L.P., S.K.L., T.A.W., N.L., J.O.R., J.L., X.H.T.W.), Baylor College of Medicine, Houston, TX

2. Department of Molecular Physiology and Biophysics (X.P., L.P., S.K.L., T.A.W., N.L., K.E.J., R.G., J.O.R., W.R.L., X.H.T.W.), Baylor College of Medicine, Houston, TX

3. Department of Bioengineering, Rice University, Houston, TX (C.L., S.H.P., G.B.).

4. Department of Medicine/Cardiology (N.L., X.H.T.W.), Baylor College of Medicine, Houston, TX

5. Department of Pediatrics (X.H.T.W.), Baylor College of Medicine, Houston, TX

6. Center for Space Medicine (X.H.T.W.), Baylor College of Medicine, Houston, TX

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference33 articles.

1. Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia

2. Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia

3. Beta-blockers in the treatment of catecholaminergic polymorphic ventricular tachycardia